Abstract:BackgroundHelicobacter pylori is estimated to affect about half the world's population and is considered as the main cause of chronic gastritis and peptic ulcer disease. Eradication of H. pylori infection accelerates ulcer healing and prevents relapse, reducing incidence of H. pylori-related gastric diseases. Numerous studies have provided evidence that the oral cavity could be a potential reservoir for H. pylori. The presence of oral H. pylori might affect the efficiency of eradication therapy and act as a causal force for its recurrence. Conversely, other investigators have indicated that the colonization and growth of H. pylori differs between the oral cavity and the stomach. Considering the open debate on the topic, it's necessary to clarify whether periodontal therapy is an effective adjunctive treatment for gastric H. pylori infection.ObjectivesTo assess the effects of periodontal therapy plus eradication therapy versus eradication therapy alone for gastric H. pylori infection. The secondary objective is to compare the non-recurrence rate at long-term follow up in different treatment groups.Search methodsWe identified randomized controlled trials (RCTs) by searching the Cochrane Central Register of Controlled Trials (CENTRAL) (2015, Issue 8), MEDLINE (1946 to August 2015), EMBASE (1980 to August 2015), and the Chinese Biomedical Database (1978 to August 2015). We also searched both ClinicalTrials.gov and the WHO ICTRP portal in October 2015. We handsearched the reference lists of included studies to identify relevant trials.Selection criteriaRCTs comparing periodontal therapy plus eradication treatment with eradication treatment alone, regardless of language of publication.Data collection and analysisTwo reviewers selected the trials that met the inclusion criteria and extracted the details of each study independently. The data were pooled using both fixed-effect and random-effects models and results calculated as odds ratios (OR) with their 95% confidence intervals (CIs) based on an intention-to-treat analysis. However, because there was little difference in the results from these two models, we only reported the results from the fixed-effect model.Main resultsWe included seven small RCTs involving 691 participants aged 17 to 78 years in our meta analyses. The primary result showed that periodontal therapy combined with H. pylori eradication treatment increased the eradication rate of gastric H. pylori compared with eradication treatment alone (OR 2.15; 95% CI 1.47 to 3.14; P < 0.0001) in people with H. pylori infection. In addition, periodontal therapy also had benefits on long-term gastric H. pylori eradication. After eradication of H. pylori, the non-recurrence rate of gastric H. pylori infection increased in participants treated with periodontal therapy compared with those who received eradication therapy alone (OR 3.60; 95% CI 2.11 to 6.15; P < 0.00001). According to the GRADE approach, the overall quality of the evidence was 'moderate' for eradication rate of gastric H. pylori and 'low' for non-recurrence rate of gastric H. pylori.Authors' conclusionsOverall, periodontal therapy could increase the efficiency of H. pylori eradication and the non-recurrence rate of gastric H. pylori. In view of the limited number and quality of included studies, it will be necessary to conduct more well-designed, multicenter, and large-scale RCTs to determine the effects of periodontal therapy in eradicating gastric H. pylori and suppressing the recurrence of this bacterium in the stomach.

Allicin as add-on therapy for Helicobacter pylori infection: A systematic review and meta-analysis

Meta-analysis for the effects of allicin on the treatment of duodenal peptic ulcer with Helicobacter pylori positive

Therapeutic Potential of Allicin-Rich Garlic Preparations: Emphasis on Clinical Evidence toward Upcoming Drugs Formulation

Allicin and health: A comprehensive review

Antifungal and antibacterial activities of allicin: A review

Allicin in Digestive System Cancer: From Biological Effects to Clinical Treatment

Current studies and potential future research directions on biological effects and related mechanisms of allicin

Effect of Vitamins C and E Supplementation on Helicobacter Pylori Eradication: a Meta-Analysis.

Comparative Effectiveness And Tolerance Of Treatments For Helicobacter Pylori: Systematic Review And Network Meta-Analysis

Study on the inhibitory effect of allicin on human gastric cancer cell line sgc-7901 and its mechanism

Allicin Bioavailability and Bioequivalence from Garlic Supplements and Garlic Foods

Allicin: A review of its important pharmacological activities

Garlic allicin as a potential agent for controlling oral pathogens

Anti-fungal Efficacy of Polybutylcyanoacrylate Nanoparticles of Allicin and Comparison With Pure Allicin

The Efficacy of Berberine-Containing Quadruple Therapy on Helicobacter Pylori Eradication in China: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

PPI‐amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta‐analysis

Periodontal Therapy As Adjunctive Treatment For Gastric Helicobacter Pylori Infection

Efficacy and safety of probiotics as adjuvant agents for Helicobacter pylori infection: A meta-analysis.

The Antibacterial Mode Of Action Of Allitridi For Its Potential Use As A Therapeutic Agent Against Helicobacter Pylori Infection

Lactobacillus Reuteri Compared with Placebo As an Adjuvant in Helicobacter Pylori Eradication Therapy: a Meta-Analysis of Randomized Controlled Trials

In vitro antibacterial effect analysis of stabilized PEGylated allicin-containing extract from Allium sativum in conjugation with other antibiotics